kosheeka (@kosheeka)

MSCs For Multiple Sclerosis According to a population-based estimate (2019), 300,000 to 400,000 individuals are affected by multiple sclerosis (MS): the most common progressive neurologic disease in the United States. Close to 80% of the patients show the relapsing-remitting form (RRMS) while two-thirds of them develop a secondary progressive form. The remaining patients show primary progressive multiple sclerosis (PPMS). Read More:- https://kosheeka.com/mscs-for-multiple-sclerosis/ #MSCsForMultipleSclerosis #StemCellsforMultipleSclerosis #MultipleSclerosisStroke #StemCellsforMS #Cellculture #customizedprimarycells #biotechcompany #stemcells #exosomes #stemcellresearchcenter #primarycells #rengeerativemedicine #bioengineering #Kosheeka